Author Question: If the reason for the difference between the true and observed score is a characteristic of the ... (Read 100 times)

2125004343

  • Hero Member
  • *****
  • Posts: 566
If the reason for the difference between the true and observed score is a characteristic of the
   person taking the test, the resulting decrease in reliability will be attributed to ____________.
 
  a) method error
  b) trait error
  c) random error
  d) nonsystematic error

Question 2

Factorial designs present many problems. Which of the following is NOT among them?
 
  a. they often require a large number of participants
  b. if the design incorporates more than two factors, the higher-order interactions may be difficult to interpret
  c. simultaneous manipulation of all the factors can be difficult
   d. they can be used with one or more factors or independent variables



SAUXC

  • Sr. Member
  • ****
  • Posts: 318
Answer to Question 1

b

Answer to Question 2

D



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

Dogs have been used in studies to detect various cancers in human subjects. They have been trained to sniff breath samples from humans that were collected by having them breathe into special tubes. These people included 55 lung cancer patients, 31 breast cancer patients, and 83 cancer-free patients. The dogs detected 54 of the 55 lung cancer patients as having cancer, detected 28 of the 31 breast cancer patients, and gave only three false-positive results (detecting cancer in people who didn't have it).

Did you know?

Famous people who died from poisoning or drug overdose include, Adolf Hitler, Socrates, Juan Ponce de Leon, Marilyn Monroe, Judy Garland, and John Belushi.

Did you know?

There are more bacteria in your mouth than there are people in the world.

Did you know?

After a vasectomy, it takes about 12 ejaculations to clear out sperm that were already beyond the blocked area.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library